468 Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Tamarind Biotamarind.bioin𝕏May 2025
Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US
Deniz Kavi(Co-founder & CEO)inSherry Liu(Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.